笙泉
笙泉 Stock: price and insider trades · Taiwan
笙泉: what insiders have been doing
We have very little insider data for 笙泉 so far: the most recent filing dates from 18 June 2024. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
Insider Decl.
10
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 23,895 of 26,912 companies
23.0
score / 100
Value22
Quality24
FCF yld-4.5%
Earn yld-7.5%
EV/EBITDA·
ROE-16%
Gross mgn33%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$23
Analyst consensus
Income statement
RevenueNT$324.2M
Gross profitNT$106.7M33% margin
EBITDA-NT$45.3M-14% margin
Net income-NT$71.5M-18.3% margin
Valuation
P/Book2.9x
Beta0.98
Balance sheet & cash
Market capNT$947.8M
Total debtNT$196.5M
Free Cash Flow-NT$42.4M
Debt / Equity7%
Profitability & ownership
ROE-16.4%
ROA-6.3%
% insiders32.2%
% institutions2.9%
Last declaration on 18 June 2024
Declarations10 total
- 32,000 sharesShareTPExTWMOPS:3122:113/06/18:溫國良之配偶:1e8ya3r
- 31,000 sharesShareTPExTWMOPS:3122:113/06/18:溫國良:0w3yogv
- 32,000 sharesShareTPExTWMOPS:3122:113/06/18:溫國良:08d416t
- 31,000 sharesShareTPExTWMOPS:3122:113/06/18:溫國良之配偶:0u6qpai
- 26,000 sharesShareTPExTWMOPS:3122:112/12/06:溫國良之配偶:1r8e2me
- 90,000 sharesShareTPExTWMOPS:3122:104/01/21:王鋕煌:0fvb01z
- 99,000 sharesShareTPExTWMOPS:3122:104/01/21:丘善文:1voo08t
- 99,000 sharesShareTPExTWMOPS:3122:104/01/21:笙德國際投資股份有限公司:15hhhl1
- 90,000 sharesShareTPExTWMOPS:3122:104/01/21:常彬:1w00hyb
- 81,000 sharesShareTPExTWMOPS:3122:104/01/21:溫國良:1c8i8jm
10 of 10 declarations
About 笙泉
笙泉 is a company listed on the XTAI market, specializing in the financial sector. It provides various financial services and investment solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
